Updated time: 2024-09-06 09:37:31
12A-1050421
TW I653990、JP 6882449、CN ZL 2017 80047543.0、AU 2017305948
Invented is a technique to achieve internal fixation of cells and organisms without compromising the structure, fluidity, biochemical complexity, and functions of the outer plasma membrane. We induced transient membrane poration to introduce crosslinkers into the inside of cells, which is enclosed by the outer plasma membrane. The crosslinkers were then activated to form polymers to achieve internal fixation. The resulting cells and organisms with internal fixation can then be applied as a robust platform for different biomedical applications.
Currently, there are no alternative existing technologies that allows preservation of cellular membranes in their native form. Alternative cell fixation methods, such as using paraformaldehyde and glutaraldehyde, compromise cell membrane fluidity and protein viability.
The present invention provides a robust inanimate platform with a cell-like exterior applicable for biomimetic interactions with chemical compounds, biomolecules, pathogens, and cells. Commercial applications of the invention include but are not limited to immune modulation, tissue engineering, agglutination assays, filtration systems for pathogen and toxin removal, and a tool for biomembrane study. In these applications, the invention will be used for biomimetic interactions with immune cells, tissue culture, agglutinating agents, pathogens, toxins, and other compounds and molecules as they preserve the fluid membrane interface.
Che-Ming Jack Hu、Hui-Wen Chen、Yuan-I Chen、Chen-Ying Chien、Jung-Chen Lin
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Internal fixation of cells and organisms and uses thereof